Cargando…
New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon?
Arterial hypertension is the most prevalent controllable disease world-wide. Yet, we still need to further improve blood pressure control, deal with resistant hypertension, and we hope to reduce risk “beyond blood pressure.” The number of candidate molecules aspiring for these aims is constantly dec...
Autores principales: | Paulis, Ludovit, Rajkovicova, Romana, Simko, Fedor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412646/ https://www.ncbi.nlm.nih.gov/pubmed/25893478 http://dx.doi.org/10.1007/s11906-015-0557-x |
Ejemplares similares
-
Novel Medical Treatments for Hypertension and Related Comorbidities
por: Davis, Jared, et al.
Publicado: (2018) -
Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill
por: Lafeber, M., et al.
Publicado: (2016) -
Excess Cardiovascular Risk in Diabetic Women: A Case for Intensive Treatment
por: Recarti, C., et al.
Publicado: (2015) -
A case of renovascular hypertension with incidental primary bilateral macronodular adrenocortical hyperplasia
por: Higashitani, Takuya, et al.
Publicado: (2020) -
Using telemedicine to manage a patient with a hypertensive emergency due to pheochromocytoma
por: Konishi, Seigo, et al.
Publicado: (2023)